Schwartz Jonathan David
SEC CIK 1726398 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RCKT | ROCKET PHARMACEUTICALS, INC. | See Remarks | 299.1K | — | $3.28M | 12 | 2022-03-30 | 2025-11-18 |
Most active insiders at RCKT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Wilson Martin | GC | — | $334.6K |
| 2 | Shah Gaurav | CEO, Dir | — | $285.6K |
| 3 | Militello John | See Remarks | — | $138.3K |
| 4 | Stevens Christopher James | COO | — | $128.3K |
| 5 | Chaudhuri Sarbani | See Remarks | — | $84.2K |
| 6 | Bjork Elisabeth | Dir | $34.4K | — |
| 7 | Schwartz Jonathan David | See Remarks | — | $7,584 |
| 8 | Fong Peter | Dir | — | — |
| 9 | Rizvi Syed Ali-aamir | Chief Medical Off | — | — |
| 10 | Malik Fady Ibraham | Dir | — | — |
Transactions 12
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-20 | 2025-11-18 | RCKT | ROCKET PHARMACEUTICALS, INC. | Schwartz Jonathan David | See Remarks | S - Sale | $2.98 | -2,545 | 299.1K | -0.8% | -$7,584 | |
| 2025-09-09 | 2025-09-08 | RCKT | ROCKET PHARMACEUTICALS, INC. | Schwartz Jonathan David | See Remarks | A - Grant | $0.00 | +80.0K | 301.6K | +36% | $0 | |
| M | 2025-08-20 | 2025-08-18+ | RCKT | ROCKET PHARMACEUTICALS, INC. | Schwartz Jonathan David | See Remarks | S - Sale | $3.05 | -2,485 | 221.6K | -1% | -$7,573 |
| 2025-08-18 | 2025-08-14 | RCKT | ROCKET PHARMACEUTICALS, INC. | Schwartz Jonathan David | See Remarks | S - Sale | $3.02 | -11.2K | 224.1K | -5% | -$33.7K | |
| 2025-05-22 | 2025-05-20 | RCKT | ROCKET PHARMACEUTICALS, INC. | Schwartz Jonathan David | See Remarks | S - Sale | $6.45 | -801 | 235.3K | -0.3% | -$5,166 | |
| 2025-05-20 | 2025-05-16 | RCKT | ROCKET PHARMACEUTICALS, INC. | Schwartz Jonathan David | See Remarks | S - Sale | $6.53 | -1,582 | 236.1K | -0.7% | -$10.3K | |
| M | 2025-02-27 | 2024-05-17+ | RCKT | ROCKET PHARMACEUTICALS, INC. | Schwartz Jonathan David | See Remarks | S - Sale | $14.84 | -15.1K | 166.9K | -8% | -$224.0K |
| D | 2025-02-13 | 2025-02-11 | RCKT | ROCKET PHARMACEUTICALS, INC. | Schwartz Jonathan David | See Remarks | A - Grant | $0.00 | +80.3K | 252.7K | +47% | $0 |
| 2023-02-22 | 2023-02-17 | RCKT | ROCKET PHARMACEUTICALS, INC. | Schwartz Jonathan David | See Remarks | S - Sale | $19.06 | -3,557 | 94.5K | -4% | -$67.8K | |
| DA | 2023-02-22 | 2023-02-14 | RCKT | ROCKET PHARMACEUTICALS, INC. | Schwartz Jonathan David | See Remarks | M - OptEx | $0.00 | +8,574 | 98.1K | +10% | $0 |
| MA | 2022-04-04 | 2022-03-30+ | RCKT | ROCKET PHARMACEUTICALS, INC. | Schwartz Jonathan David | See Remarks | S - Sale | $16.21 | -135.0K | 170.5K | -44% | -$2.19M |
| M | 2022-04-01 | 2022-03-30 | RCKT | ROCKET PHARMACEUTICALS, INC. | Schwartz Jonathan David | See Remarks | S - Sale | $16.41 | -45.0K | 179.5K | -20% | -$738.7K |
Purchase Sale Sale after option exercise All abbreviations